Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: Possible involved mechanisms

Peptides

Volumn 86, Issue , 2016, Pages 102-111

  Ahshin Majd, Siamak ^a   Zamani, Samira ^a   Kiamari, Taktom ^a   Kiasalari, Zahra ^a   Baluchnejadmojarad, Tourandokht ^b   Roghani, Mehrdad ^a  

^a SHAHED UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carnosine; Cognition; Diabetes mellitus; Learning and memory; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; CARNOSINE; CATALASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; GLUTATHIONE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; LEARNING DISORDER; LIPID PEROXIDATION; LONG TERM CARE; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECALL; RECOGNITION; SPATIAL MEMORY; STEP-THROUGH PASSIVE AVOIDANCE TEST; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; Y-MAZE TEST; ANIMAL; COGNITION; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; MAZE TEST; METABOLISM; PRECLINICAL STUDY; WISTAR RAT;

ANIMALS; CARNOSINE; COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; HIPPOCAMPUS; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS, WISTAR; STREPTOZOCIN;

EID: 84993949903     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.10.008     Document Type: Article

References (111)

1. [1] Afshin-Majd, S., Khalili, M., Roghani, M., Mehranmehr, N., Baluchnejadmojarad, T., Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat. Mol. Neurobiol. 51 (2015), 1064–1070.
2. [2] Aloisi, A., Barca, A., Romano, A., Guerrieri, S., Storelli, C., Rinaldi, R., et al. Anti-aggregating effect of the naturally occurring dipeptide carnosine on abeta1-42 fibril formation. PLoS One, 8, 2013, e68159.
3. [3] Alrefaie, Z., Alhayani, A., Vitamin D(3) improves decline in cognitive function and cholinergic transmission in prefrontal cortex of streptozotocin-induced diabetic rats. Behav. Brain Res. 287 (2015), 156–162.
4. [4] Alsheblak, M.M., Elsherbiny, N.M., El-Karef, A., El-Shishtawy, M.M., Protective effects of L-carnosine on CCl4 −induced hepatic injury in rats. Eur. Cytokine Netw. 27 (2016), 6–15.
5. [5] Ansurudeen, I., Sunkari, V.G., Grunler, J., Peters, V., Schmitt, C.P., Catrina, S.B., et al. Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 43 (2012), 127–134.
6. [6] Aydin, A.F., Coban, J., Dogan-Ekici, I., Betul-Kalaz, E., Dogru-Abbasoglu, S., Uysal, M., Carnosine and taurine treatments diminished brain oxidative stress and apoptosis in D-galactose aging model. Metab. Brain Dis. 31 (2016), 337–345.
7. [7] Baky, N.A., Fadda, L., Al-Rasheed, N.M., Al-Rasheed, N.M., Mohamed, A., Yacoub, H., Neuroprotective effect of carnosine and cyclosporine-A against inflammation apoptosis, and oxidative brain damage after closed head injury in immature rats. Toxicol. Mech. Methods 26 (2016), 1–10.
8. [8] Baluchnejadmojarad, T., Roghani, M., Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress. Iran. J. Pharm. Res. 11 (2012), 1243–1253.
9. [9] Baykara, B., Micili, S.C., Tugyan, K., Tekmen, I., Bagriyanik, H., Sonmez, U., et al. The protective effects of carnosine in alcohol-induced hepatic injury in rats. Toxicol. Ind. Health 30 (2014), 25–32.
10. [10] Biessels, G.J., Strachan, M.W., Visseren, F.L., Kappelle, L.J., Whitmer, R.A., Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2 (2014), 246–255.
11. [11] Boldyrev, A.A., Aldini, G., Derave, W., Physiology and pathophysiology of carnosine. Physiol. Rev. 93 (2013), 1803–1845.
12. [12] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
13. [13] Bramham, C.R., Messaoudi, E., BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76 (2005), 99–125.
14. [14] Brands, A.M., Biessels, G.J., de Haan, E.H., Kappelle, L.J., Kessels, R.P., The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 (2005), 726–735.
15. [15] Brown, B.E., Kim, C.H., Torpy, F.R., Bursill, C.A., McRobb, L.S., Heather, A.K., et al. Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E(-/-) mice. Atherosclerosis 232 (2014), 403–409.
16. [16] Calabrese, V., Cornelius, C., Mancuso, C., Barone, E., Calafato, S., Bates, T., et al. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front. Biosci. (Landmark Edition) 14 (2009), 376–397.
17. [17] Cararo, J.H., Streck, E.L., Schuck, P.F., Ferreira Gda, C., Carnosine and related peptides therapeutic potential in age-Related disorders. Aging Dis. 6 (2015), 369–379.
18. [18] Claiborne, A., Catalase activity. Greenwald, R.A., (eds.) CRC Handbook of Methods for Oxygen Radical Research, 1985, CRC, Boca Raton, FL, 283–284.
19. [19] Corona, C., Frazzini, V., Silvestri, E., Lattanzio, R., La Sorda, R., Piantelli, M., et al. Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice. PLoS One, 6, 2011, e17971.
20. [20] Crane, P.K., Walker, R., Larson, E.B., Glucose levels and risk of dementia. New Engl. J. Med. 369 (2013), 1863–1864.
21. [21] Dang, J., Brandenburg, L.O., Rosen, C., Fragoulis, A., Kipp, M., Pufe, T., et al. Nrf2 expression by neurons astroglia, and microglia in the cerebral cortical penumbra of ischemic rats. J. Mol. Neurosci. 46 (2012), 578–584.
22. [22] Davinelli, S., Di Marco, R., Bracale, R., Quattrone, A., Zella, D., Scapagnini, G., Synergistic effect of L-Carnosine and EGCG in the prevention of physiological brain aging. Curr. Pharm. Des. 19 (2013), 2722–2727.
23. [23] de Courten, B., Jakubova, M., de Courten, M.P., Kukurova, I.J., Vallova, S., Krumpolec, P., et al. Effects of carnosine supplementation on glucose metabolism: pilot clinical trial. Obesity (Silver Spring, Md.) 24 (2016), 1027–1034.
24. [24] Demirel, C., Balci, S.O., Korkmaz, H., Akarsu, E., Relationship between the level of hippocampal leptin receptor gene expression and learning performance in diabetic rats. Exp. Clin. Endocrinol. Diabetes 122 (2014), 615–619.
25. [25] Derave, W., Everaert, I., Beeckman, S., Baguet, A., Muscle carnosine metabolism and beta-alanine supplementation in relation to exercise and training. Sports Med. 40 (2010), 247–263.
26. [26] Di Marco, E., Jha, J.C., Sharma, A., Wilkinson-Berka, J.L., Jandeleit-Dahm, K.A., de Haan, J.B., Are reactive oxygen species still the basis for diabetic complications?. Clin. Sci. (Lond.) 129 (2015), 199–216.
27. [27] El Batsh, M.M., El Batch, M.M., Shafik, N.M., Younos, I.H., Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 769 (2015), 297–305.
28. [28] Ellman, G.L., Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82 (1959), 70–77.
29. [29] Ellman, G.L., Courtney, K.D., Andres, V. Jr., Feather-Stone, R.M., A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961), 88–95.
30. [30] Fallahi, F., Roghani, M., Moghadami, S., Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats. Indian J. Pharmacol. 44 (2012), 382–386.
31. [31] Fleisher-Berkovich, S., Abramovitch-Dahan, C., Ben-Shabat, S., Apte, R., Beit-Yannai, E., Inhibitory effect of carnosine and N-acetyl carnosine on LPS-induced microglial oxidative stress and inflammation. Peptides 30 (2009), 1306–1312.
32. [32] Gaspar, J.M., Baptista, F.I., Macedo, M.P., Ambrosio, A.F., Inside the diabetic brain: role of different players involved in cognitive decline. ACS Chem. Neurosci. 7 (2016), 131–142.
33. [33] Gumuslu, E., Mutlu, O., Celikyurt, I.K., Ulak, G., Akar, F., Erden, F., et al. Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice. Fundam. Clin. Pharmacol., 2016 in press.
34. [34] Gumuslu, E., Mutlu, O., Celikyurt, I.K., Ulak, G., Akar, F., Erden, F., et al. Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice. Fundam. Clin. Pharmacol. 30 (2016), 376–384.
35. [35] Habas, A., Hahn, J., Wang, X., Margeta, M., Neuronal activity regulates astrocytic Nrf2 signaling. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 18291–18296.
36. [36] Hasanein, P., Teimuri-Far, M., Protective effect of bioactive peptide carnosine against lead-induced oxidative stress in kidney of rats. Cell. Mol. Biol. (Noisy-le-grand) 61 (2015), 8–14.
37. [37] Herculano, B., Tamura, M., Ohba, A., Shimatani, M., Kutsuna, N., Hisatsune, T., beta-alanyl-L-histidine rescues cognitive deficits caused by feeding a high fat diet in a transgenic mouse model of Alzheimer's disease. J. Alzheimer's Dis. 33 (2013), 983–997.
38. [38] Hipkiss, A.R., Brownson, C., Bertani, M.F., Ruiz, E., Ferro, A., Reaction of carnosine with aged proteins: another protective process?. Ann. N. Y. Acad. Sci. 959 (2002), 285–294.
39. [39] Hoffman, J.R., Ostfeld, I., Stout, J.R., Harris, R.C., Kaplan, Z., Cohen, H., beta-Alanine supplemented diets enhance behavioral resilience to stress exposure in an animal model of PTSD. Amino Acids 47 (2015), 1247–1257.
40. [40] Huang, Y.N., Wu, C.H., Lin, T.C., Wang, J.Y., Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity. Toxicol. Appl. Pharmacol. 240 (2009), 315–326.
41. [41] Imam, K., Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Adv. Exp. Med. Biol. 771 (2012), 340–355.
42. [42] Ji, Y.S., Park, J.W., Heo, H., Park, J.S., Park, S.W., The neuroprotective effect of carnosine (beta-alanyl-L-histidine) on retinal ganglion cell following ischemia-reperfusion injury. Curr. Eye Res. 39 (2014), 634–641.
43. [43] Joghataie, M.T., Roghani, M., Jalali, M.R., Baluchnejadmojarad, T., Sharayeli, M., Dendritic spine changes in medial prefrontal cortex of male diabetic rats using Golgi-impregnation method. Arch. Iran. Med. 10 (2007), 54–58.
44. [44] Jolivalt, C.G., Hurford, R., Lee, C.A., Dumaop, W., Rockenstein, E., Masliah, E., Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp. Neurol. 223 (2010), 422–431.
45. [45] Kalalian-Moghaddam, H., Baluchnejadmojarad, T., Roghani, M., Goshadrou, F., Ronaghi, A., Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur. J. Pharmacol. 698 (2013), 259–266.
46. [46] Karkkainen, V., Pomeshchik, Y., Savchenko, E., Dhungana, H., Kurronen, A., Lehtonen, S., et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells 32 (2014), 1904–1916.
47. [47] Khare, P., Datusalia, A.K., Sharma, S.S., Parthenolide, an NF-kappaB inhibitor ameliorates diabetes-induced behavioural deficit, neurotransmitter imbalance and neuroinflammation in type 2 diabetes rat model. Neuromolecular Med., 2016 (in press).
48. [48] Kiasalari, Z., Roghani, M., Khalili, M., Rahmati, B., Baluchnejadmojarad, T., Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy. Pharm. Biol. 51 (2013), 1572–1578.
49. [49] Kimura, N., Diabetes mellitus induces alzheimer's disease pathology: histopathological evidence from animal models. Int. J. Mol. Sci., 17, 2016.
50. [50] Li, C., Zhao, R., Gao, K., Wei, Z., Yin, M.Y., Lau, L.T., et al. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 8 (2011), 67–80.
51. [51] Li, W., Kong, A.N., Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48 (2009), 91–104.
52. [52] Lima, M.M., Targa, A.D., Noseda, A.C., Rodrigues, L.S., Delattre, A.M., dos Santos, F.V., et al. Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?. CNS Neurol. Disord. Drug Targets 13 (2014), 418–428.
53. [53] Liu, X., Liu, M., Mo, Y., Peng, H., Gong, J., Li, Z., et al. Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Iran. J. Basic Med. Sci. 19 (2016), 417–422.
54. [54] Liu, X., Mo, Y., Gong, J., Li, Z., Peng, H., Chen, J., et al. Puerarin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Metab. Brain Dis. 31 (2016), 417–423.
55. [55] Liu, Y., Liu, H., Yang, J., Liu, X., Lu, S., Wen, T., et al. Increased amyloid beta-peptide (1–40) level in brain of streptozotocin-induced diabetic rats. Neuroscience 153 (2008), 796–802.
56. [56] Ma, C., Long, H., Protective effect of betulin on cognitive decline in streptozotocin (STZ)-induced diabetic rats. Neurotoxicology 57 (2016), 104–111.
57. [57] Ma, J., Xiong, J.Y., Hou, W.W., Yan, H.J., Sun, Y., Huang, S.W., et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci. Ther. 18 (2012), 745–753.
58. [58] Ma, P., Mao, X.Y., Li, X.L., Ma, Y., Qiao, Y.D., Liu, Z.Q., et al. Baicalin alleviates diabetesassociated cognitive deficits via modulation of mitogen-activated protein kinase signaling, brainderived neurotrophic factor and apoptosis. Mol. Med. Rep. 12 (2015), 6377–6383.
59. [59] Maiese, K., Chong, Z.Z., Shang, Y.C., Mechanistic insights into diabetes mellitus and oxidative stress. Curr. Med. Chem. 14 (2007), 1729–1738.
60. [60] Manschot, S.M., Biessels, G.J., Rutten, G.E., Kessels, R.P., Gispen, W.H., Kappelle, L.J., Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. J. Neurol. Sci. 264 (2008), 157–162.
61. [61] Milewski, K., Hilgier, W., Fresko, I., Polowy, R., Podsiadlowska, A., Zolocinska, E., et al. Carnosine reduces oxidative stress and reverses attenuation of righting and postural reflexes in rats with thioacetamide-induced liver failure. Neurochem. Res. 41 (2016), 376–384.
62. [62] Mirshekar, M., Roghani, M., Khalili, M., Baluchnejadmojarad, T., Arab Moazzen, S., Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress. Iran. Biomed. J. 14 (2010), 33–39.
63. [63] Moghaddam, H.K., Baluchnejadmojarad, T., Roghani, M., Goshadrou, F., Ronaghi, A., Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. Metab. Brain Dis. 28 (2013), 421–428.
64. [64] Moghaddam, H.K., Baluchnejadmojarad, T., Roghani, M., Khaksari, M., Norouzi, P., Ahooie, M., et al. Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats. Mol. Neurobiol. 49 (2014), 820–826.
65. [65] Moreira, R.O., Campos, S.C., Soldera, A.L., Type 2 diabetes mellitus and alzheimer's disease: from physiopathology to treatment implications. Diabetes Metab. Res. Rev., 2013 (in press).
66. [66] Motawi, T.K., Darwish, H.A., Hamed, M.A., El-Rigal, N.S., Naser, A.F., A therapeutic insight of niacin and coenzyme Q10 against diabetic encephalopathy in rats. Mol. Neurobiol., 2016 (in press).
67. [67] Nagai, K., Niijima, A., Yamano, T., Otani, H., Okumra, N., Tsuruoka, N., et al. Possible role of L-carnosine in the regulation of blood glucose through controlling autonomic nerves. Exp. Biol. Med. (Maywood) 228 (2003), 1138–1145.
68. [68] Nagayach, A., Patro, N., Patro, I., Astrocytic and microglial response in experimentally induced diabetic rat brain. Metab. Brain Dis. 29 (2014), 747–761.
69. [69] Nardin, P., Zanotto, C., Hansen, F., Batassini, C., Gasparin, M.S., Sesterheim, P., et al. Peripheral levels of ages and astrocyte alterations in the hippocampus of STZ-diabetic rats. Neuroche. Res. 41 (2016), 2006–2016.
70. [70] Nasri, S., Roghani, M., Baluchnejadmojarad, T., Balvardi, M., Rabani, T., Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats. Phytother. Res. 26 (2012), 1205–1210.
71. [71] Nasri, S., Roghani, M., Baluchnejadmojarad, T., Rabani, T., Balvardi, M., Vascular mechanisms of cyanidin-3-glucoside response in streptozotocin-diabetic rats. Pathophysiology 18 (2011), 273–278.
72. [72] Neumann, H., Schweigreiter, R., Yamashita, T., Rosenkranz, K., Wekerle, H., Barde, Y.A., Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22 (2002), 854–862.
73. [73] Oliveira, W.H., Nunes, A.K., Franca, M.E., Santos, L.A., Los, D.B., Rocha, S.W., et al. Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice. Brain Res. 1644 (2016), 149–160.
74. [74] Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A., Breteler, M.M., Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53 (1999), 1937–1942.
75. [75] Otto-Buczkowska, E., Kazibutowska, Z., Soltyk, J., Machnica, L., Neuropathy and type 1 diabetes mellitus. Pediatr. Endocrinol. Diabetes Metab. 14 (2008), 109–116.
76. [76] Pancani, T., Anderson, K.L., Brewer, L.D., Kadish, I., DeMoll, C., Landfield, P.W., et al. Effect of high-fat diet on metabolic indices cognition, and neuronal physiology in aging F344 rats. Neurobiol. Aging 34 (2013), 1977–1987.
77. [77] Pfister, F., Riedl, E., Wang, Q., vom Hagen, F., Deinzer, M., Harmsen, M.C., et al. Oral carnosine supplementation prevents vascular damage in experimental diabetic retinopathy. Cell. Physiol. Biochem. 28 (2011), 125–136.
78. [78] Ricciardi-Castagnoli, P., Pirami, L., Righi, M., Sacerdote, P., Locatelli, V., Bianchi, M., et al. Cellular sources and effects of tumor necrosis factor-alpha on pituitary cells and in the central nervous system. Ann. N. Y. Acad. Sci. 594 (1990), 156–168.
79. [79] Riedl, E., Pfister, F., Braunagel, M., Brinkkotter, P., Sternik, P., Deinzer, M., et al. Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats. Cell. Physiol. Biochem. 28 (2011), 279–288.
80. [80] Rios, J.L., Francini, F., Schinella, G.R., Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 81 (2015), 975–994.
81. [81] Roghani-Dehkordi, F., Roghani, M., Baluchnejadmojarad, T., Diosgenin mitigates streptozotocin diabetes-induced vascular dysfunction of the rat aorta: the involved mechanisms. J. Cardiovasc. Pharmacol. 66 (2015), 584–592.
82. [82] Roghani, M., Baluchnejadmojarad, T., Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. 51 (2009), 84–89.
83. [83] Roghani, M., Joghataie, M.T., Jalali, M.R., Baluchnejadmojarad, T., Time course of changes in passive avoidance and Y-maze performance in male diabetic rats. Iran. Biomed. J. 10 (2006), 99–104.
84. [84] Roghani, M., Joghataie, M.T., Jalili, M.R., Baluchnejadmojarad, T., Time course of changes in passive avoidance and Y-maze performance in male diabetic rats. Iran. Biomed. J. 10 (2006), 99–104.
85. [85] Roghani, M., Taghi Joghataie, M., Jalali Nadoushan, M.R., Baluchnejadmojarad, T., Roghani Dehkordi, F., Morphological changes in hippocampal CA1 area in diabetic rats: a Golgi-impregnation study. Iran. J. Pathol 1 (2006), 135–140.
86. [86] Sachdeva, A.K., Kuhad, A., Chopra, K., Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction. Pharmacol. Biochem. Behav. 127 (2014), 101–110.
87. [87] Sandberg, M., Patil, J., D'Angelo, B., Weber, S.G., Mallard, C., NRF2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacology 79 (2014), 298–306.
88. [88] Sedlak, J., Lindsay, R.H., Estimation of total protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25 (1968), 192–205.
89. [89] Shen, Y., Fan, Y., Dai, H., Fu, Q., Hu, W., Chen, Z., Neuroprotective effect of carnosine on necrotic cell death in PC12 cells. Neurosci. Lett. 414 (2007), 145–149.
90. [90] Shih, R.-H., Wang, C.-Y., Yang, C.-M., NF-kappaB Signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci., 8, 2015, 77.
91. [91] Sohanaki, H., Baluchnejadmojarad, T., Nikbakht, F., Roghani, M., Pelargonidin improves memory deficit in amyloid beta25-35 rat model of Alzheimer's disease by inhibition of glial activation cholinesterase, and oxidative stress. Biomed. Pharmacother. 83 (2016), 85–91.
92. [92] Song, F., Qi, X., Chen, W., Jia, W., Yao, P., Nussler, A.K., et al. Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1. Eur. J. Nutr. 46 (2007), 61–69.
93. [93] Sorensen, B.M., Houben, A.J., Berendschot, T.T., Schouten, J.S., Kroon, A.A., van der Kallen, C.J., et al. Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the Maastricht study. Circulation, 2016 (in press).
94. [94] Sun, J.S., Yang, Y.J., Zhang, Y.Z., Huang, W., Li, Z.S., Zhang, Y., Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol. Med. Rep. 12 (2015), 2677–2682.
95. [95] Syapin, P.J., Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 155 (2008), 623–640.
96. [96] Szczesniak, D., Budzen, S., Kopec, W., Rymaszewska, J., Anserine and carnosine supplementation in the elderly: effects on cognitive functioning and physical capacity. Arch. Gerontol. Geriatr. 59 (2014), 485–490.
97. [97] Tamaddonfard, E., Farshid, A.A., Asri-Rezaee, S., Javadi, S., Khosravi, V., Rahman, B., et al. Crocin improved learning and memory impairments in streptozotocin-induced diabetic rats. Iran. J. Basic Med. Sci. 16 (2013), 91–100.
98. [98] Thakur, A.K., Rai, G., Chatterjee, S.S., Kumar, V., Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats. Pharm. Biol, 2016, 1–11.
99. [99] Thounaojam, M.C., Nammi, S., Jadeja, R., Natural products for the treatment of obesity, metabolic syndrome, and type 2 diabetes 2014. Evid. Based Complement Altern. Med., 2015, 2015, 392681.
100. [100] Vomhof-Dekrey, E.E., Picklo, M.J. Sr., The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism. J. Nutr. Biochem. 23 (2012), 1201–1206.
101. [101] Wang, D.C., Chen, S.S., Lee, Y.C., Chen, T.J., Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Neurosci. Lett. 398 (2006), 78–82.
102. [102] Wang, J.Q., Yin, J., Song, Y.F., Zhang, L., Ren, Y.X., Wang, D.G., et al. Brain aging and AD-like pathology in streptozotocin-induced diabetic rats. J. Diabetes Res., 2014, 2014, 796840.
103. [103] Wang, X., Zhao, L., Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway. Biochem. Biophys. Res. Commun. 473 (2016), 428–434.
104. [104] Xu, M., He, R.R., Zhai, Y.J., Abe, K., Kurihara, H., Effects of carnosine on cyclophosphamide-induced hematopoietic suppression in mice. Am. J. Chin. Med. 42 (2014), 131–142.
105. [105] Yapislar, H., Aydogan, S., Effect of carnosine on erythrocyte deformability in diabetic rats. Arch. Physiol. Biochem. 118 (2012), 265–272.
106. [106] Yapislar, H., Taskin, E., L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats. Med. Sci. Monit. 20 (2014), 399–405.
107. [107] Yates, K.F., Sweat, V., Yau, P.L., Turchiano, M.M., Convit, A., Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 2060–2067.
108. [108] Yay, A., Akkus, D., Yapislar, H., Balcioglu, E., Sonmez, M.F., Ozdamar, S., Antioxidant effect of carnosine treatment on renal oxidative stress in streptozotocin-induced diabetic rats. Biotech. Histochem. 89 (2014), 552–557.
109. [109] Zhang, H., Guo, S., Zhang, L., Jia, L., Zhang, Z., Duan, H., et al. Treatment with carnosine reduces hypoxia-ischemia brain damage in a neonatal rat model. Eur. J. Pharmacol. 727 (2014), 174–180.
110. [110] Zhen, Y.F., Zhang, J., Liu, X.Y., Fang, H., Tian, L.B., Zhou, D.H., et al. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl) 227 (2013), 93–100.
111. [111] Zhong, Y., Zhu, Y., He, T., Li, W., Yan, H., Miao, Y., Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels. Neurosci. Lett. 610 (2016), 171–176.